Flubrotizolam
Flubrotizolam is a thienotriazolodiazepine derivative, which is a class of benzodiazepine analogs. It is known for its potent sedative, hypnotic, and anxiolytic properties. Flubrotizolam is structurally related to other thienotriazolodiazepines such as etizolam and flubromazolam.
Chemical Structure and Properties[edit]
Flubrotizolam has a chemical structure that includes a thieno ring fused to a triazolo ring, which is then attached to a diazepine ring. This unique structure contributes to its high potency and efficacy. The molecular formula of Flubrotizolam is C17H12BrClN4S.
Pharmacology[edit]
Flubrotizolam acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased inhibitory neurotransmission, leading to its sedative and anxiolytic effects. The drug has a high affinity for the GABA_A receptor, which accounts for its potent effects even at low doses.
Medical Uses[edit]
Flubrotizolam is primarily used for its anxiolytic, hypnotic, and sedative properties. It is often prescribed for the short-term treatment of severe insomnia and anxiety disorders. Due to its high potency, it is typically used in very small doses.
Side Effects[edit]
Common side effects of Flubrotizolam include drowsiness, dizziness, and muscle relaxation. In some cases, it may cause amnesia, confusion, and impaired coordination. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.
Legal Status[edit]
The legal status of Flubrotizolam varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and dependence. It is important to consult local regulations before obtaining or using this medication.
See Also[edit]
References[edit]
External Links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
